Two series of 4H-pyrido[4,3-e]-1,2,4-thiadiazine derivatives 3-5 and 7-12 were synthesized by the reactions of 3-methylthiopyrido[4,3-e]-1,4,2-dithiazine 1,1-dioxide 1 with 2-or 6-hydrazinoazines and 2-aminophenols or 2-aminothiophenol, respectively. Aminolysis of 8 (R ¼ Me, Y ¼ O) afforded the corresponding 3-(R-amino)-4-(2-hydroxy-5-methylphenyl)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides 13-18. The structures of these compounds were confirmed on the basis of elemental analysis, spectral data, and X-ray crystallography. Compounds 3-5, 7-10, 12-15, and 17-18 were screened in vitro for antibacterial activity. Moreover, preliminary in vitro anticancer assay was performed for compounds 3, 7, 10, 11-13, and 17-18 at the National Cancer Institute (Bethesda, MD) at a single dose (10 lM) in the full NCI 60 cell panel.